Safety and Effectiveness of PCSK9 Inhibitors in Orthotopic Heart Transplant Patients

Statin medications are recommended in patients after heart transplantation, but are sometimes poorly tolerated in the setting of concomitant use of calcineurin inhibitors. Alternative agents are often considered including PCSK9 inhibitors (PCSK9i). We sought to investigate the effects of PCSK9i use after heart transplant.

Source: Journal of Cardiac Failure - September 30, 2020 Category: Cardiology Authors: Yasser Sammour, Bethany A. Austin, Michael Borkon, Mark P. Everley, Timothy J. Fendler, Taiyeb M. Khumri, Stephanie L. Lawhorn, Anthony Magalski, Michael E. Nassif, Deepthi Vodnala, Andrew C. Kao, Brett W. Sperry Tags: 054 Source Type: research